Explore / Peer-reviewed article
Peer-reviewed article

Harnessing Artificial Intelligence to Overcome Key Challenges in Psychedelic Research and Therapy.

Kargbo RBiD

ACS medicinal chemistry lettersDec 11, 2024United States1 citationsDOI: 10.1021/acsmedchemlett.4c00548

Abstract

Artificial intelligence (AI) offers transformative potential in psychedelic research by addressing limitations in personalized treatment, predicting therapeutic outcomes, and understanding complex biological and environmental factors. AI-driven models provide new insights into long-term efficacy, set and setting optimization, and alternative treatment methods, advancing psychedelic therapy into personalized medicine.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psychedelics

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.